Chronic ethanol use in alcoholic beverages by HIV-infected patients affects the therapeutic window of stavudine, lamivudine and nevirapine during the 9-month follow-up period: using chronic alcohol-use biomarkers

• Published in: Journal of basic and clinical physiology and pharmacology p. 1
• Main Authors: Bbosa, Godfrey S, Kyegombe, David B, Anokbonggo, William W, Ogwal-Okeng, Jasper, Musoke, David, Odda, John, Lubega, Aloysius, Ntale, Muhammad
• Format: Journal Article
• Language: English
• Published: Germany 27.01.2014

Abstract Background: Chronic ethanol use is a global problem including among HIV-infected patients on stavudine/lamivudine/nevirapine (d4T/3TC/NVP) regimen. The study determined the effect of chronic ethanol use on the therapeutic window of d4T, 3TC and NVP in HIV-infected patients using alcohol-use...